Enspectra Health Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$4M
- Investors
-
10
Enspectra Health General Information
Description
Developer of an imaging diagnostic device system designed to simplify the way physicians evaluate a broad spectrum of skin conditions. The company's device specializes in combining reflectance confocal and multiphoton laser scanning microscopy to generate real-time, multispectral images spanning wavelengths not seen with the naked eye, enabling dermatologists to improve the diagnostics and treatment of skin cancers.
Contact Information
Website
www.enspectrahealth.com
Formerly Known As
Zebra Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- 2495 Hospital Drive
- Suite 300
- Mountain View, CA 94040
- United States
+1 (650) 000-0000
Enspectra Health Timeline
Enspectra Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 26-May-2021 | $4M | 00.000 | Completed | Product Development | |
| 6. Grant | 21-Apr-2020 | 00.000 | 00.000 | Completed | Product Development | |
| 5. Later Stage VC (Series A) | 06-Aug-2019 | 00.000 | 00.000 | 000.00 | Completed | Product Development |
| 4. Accelerator/Incubator | 22-Jun-2018 | 00000 | Completed | Product Development | ||
| 3. Grant | 01-Jan-2017 | 00000 | 00000 | Completed | Product Development | |
| 2. Seed Round | 17-Feb-2015 | $700K | $700K | 00.000 | Completed | Product Development |
| 1. Accelerator/Incubator | Completed | Startup |
Enspectra Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Enspectra Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an imaging diagnostic device system designed to simplify the way physicians evaluate a broad spectrum of sk
Diagnostic Equipment
Mountain View, CA
15
As of 2022
00.000
0000000000
00.000
000000
nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
Norcross, GA
000
As of 0000
000.00
000000000 00
000.00
000000
dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000 000000000
Sunnyvale, CA
0000
As of 0000
000.00
00
0000-00-00
000000&0
000.00
Add Comparison
Enspectra Health Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immucor | Private Equity-Backed | Norcross, GA | 000 | 000.00 | 000000000 00 | 000.00 |
| 0000000 | Formerly VC-backed | Sunnyvale, CA | 0000 | 000.00 | 000000&0 | 000.00 |
| 0000000 0000000 | Corporate Backed or Acquired | Brea, CA | 00000 | 000000&0 | ||
| 000000 000000000 | Formerly VC-backed | Abingdon, United Kingdom | 000 | 00000 | 000000&0 | 00000 |
| 00000000 000000000 | Corporation | Cincinnati, OH | 000 | 00000000 |
Enspectra Health Patents
Enspectra Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210169336-A1 | Methods and systems for identifying tissue characteristics | Pending | 13-Nov-2018 | 0000000000 | |
| US-20200196938-A1 | Systems and methods for imaging and measurement of sarcomeres | Pending | 28-Apr-2017 | 0000000000 | |
| EP-3614915-A4 | Systems and methods for imaging and measurement of sarcomeres | Pending | 28-Apr-2017 | 0000000000 | 0 |
| EP-3614915-A1 | Systems and methods for imaging and measurement of sarcomeres | Pending | 28-Apr-2017 | 0000000000 | |
| CA-3016468-A1 | Non-invasive detection of skin disease | Pending | 08-Mar-2016 | A61B5/0077 |
Enspectra Health Executive Team (7)
Enspectra Health Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gabriel Sanchez Ph.D | Enspectra Health | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Scott Delp Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| Xuhui Shao Ph.D | Foothill Ventures | Board Member | 000 0000 |
Enspectra Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Enspectra Health Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Cancer Institute | Government | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| Foothill Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Heuristic Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Social Starts | Venture Capital | Minority | 000 0000 | 000000 0 |